12 results
POS AM
LSB
LakeShore Biopharma Co., Ltd
23 Jan 24
Prospectus update (post-effective amendment)
4:18pm
as the related manufacturing, storage, testing, delivery and other procedures are required to meet certain quality standards to ensure product safety … actions and contractual liabilities.
Product safety and quality are critical to YS Group’s business. For example, YS Group’s production was halted
424B3
LSB
LakeShore Biopharma Co., Ltd
15 Aug 23
Prospectus supplement
8:00am
quality standards to ensure product safety and efficacy. YS Group cannot assure you that its quality control and assurance system can provide … conditions, and subject YS Group to regulatory actions and contractual liabilities.
Product safety and quality are critical to YS Group’s business
POS AM
LSB
LakeShore Biopharma Co., Ltd
8 Aug 23
Prospectus update (post-effective amendment)
4:06pm
are required to meet certain quality standards to ensure product safety and efficacy. YS Group cannot assure you that its quality control and assurance … and financial conditions, and subject YS Group to regulatory actions and contractual liabilities.
Product safety and quality are critical to YS
20-F
2023 FY
LSB
LakeShore Biopharma Co., Ltd
26 Jul 23
Annual report (foreign)
4:02pm
standards to ensure product safety and efficacy. We cannot assure you that our quality control and assurance system can provide adequate … to regulatory actions and contractual liabilities.
Product safety and quality is critical to our business. For example, our production was halted
424B3
8flgvzhq
5 Jun 23
Prospectus supplement
4:03pm
F-1/A
w93vxzl
12 May 23
Registration statement (foreign) (amended)
4:05pm
F-1
l5az43
12 Apr 23
Registration statement (foreign)
8:49am
F-4
bzd52ha
28 Dec 22
Registration of securities (foreign)
6:58am
DRS/A
h7rm37s
7 Dec 22
Draft registration statement (amended)
12:00am
DRS/A
vhftggx
14 Nov 22
Draft registration statement (amended)
12:00am
DRS
m4xzlc5t4t1
3 Oct 22
Draft registration statement
12:00am
- Prev
- 1
- Next